Skip to Content

Edrophonium use while Breastfeeding

Drugs containing Edrophonium: Reversol, Tensilon, Enlon, Enlon-Plus

Medically reviewed by Drugs.com. Last updated on Jan 30, 2021.

Edrophonium Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of edrophonium during breastfeeding. However, because of its short half-life and quaternary ammonium structure, it is unlikely to be excreted into breastmilk or orally absorbed by the infant. Administering the drug just after breastfeeding and waiting 2 to 3 hours before breastfeeding again should avoid any adverse reactions in the infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Edrophonium

CAS Registry Number

312-48-1

Drug Class

  • Breast Feeding
  • Lactation
  • Cholinesterase Inhibitors
  • Diagnostic Agents
  • Parasympathomimetics

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

More about edrophonium

Consumer resources

Other brands
Reversol, Enlon

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.